KRAS and rectal cancer: Moreover, wavelet features derived from MR, PWI and DWI were associated with KRAS mutation in rectal cancer patients in [112], achieving a final AUC of 0.651 (95% CI, 0.539–0.763) on a temporally independent validation cohort.